SCHEMBL20416635

SCHEMBL20416635

COC(=O)C(C)(C)Nc1cccc(CO[Si](C)(C)C(C)(C)C)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
KMT2A Q03164 1/20 0.37
BACE1 P56817 1/20 0.37
MAPK1 P28482 1/20 0.36
NR3C2 P08235 1/20 0.34
FPR2 P25090 1/20 0.34
SCN9A Q15858 1/20 0.34
CNR2 P34972 3/20 0.34
PDE5A O76074 2/20 0.33
IRAK4 Q9NWZ3 1/20 0.33
LATS1 O95835 1/20 0.33
GAA P10253 1/20 0.33
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TACR1 P25103 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20416633 0.88 BACE1 (0.37) MEN1OPRM1OPRD1KMT2ABACE1
SCHEMBL20416632 0.82 MEN1 (0.41) MEN1OPRM1OPRD1KMT2AMAPK1
SCHEMBL20436541 0.82 BACE1 (0.34) BACE1PDE5AIRAK4
SCHEMBL4505482 0.81 PDE5A (0.42) MEN1KMT2ABACE1NR3C2PDE5A
SCHEMBL20416904 0.81 PTGER2 (0.39) BACE1
SCHEMBL20416608 0.80 MEN1 (0.38) MEN1OPRM1OPRD1KMT2ABACE1
SCHEMBL20387967 0.79 NPC1 (0.41) BACE1NR3C2PDE5AGAACHRNB2
SCHEMBL28521553 0.79 APP (0.40) BACE1IRAK4
SCHEMBL3530865 0.78 SMN1; SMN2 (0.40) MEN1KMT2ABACE1NR3C2PDE5A
SCHEMBL11915102 0.77 BACE1 (0.33) BACE1NR3C2IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4310082-A2 AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS Arcus Biosciences, Inc. (US) 2024-01-24 EP disclosed
EP-3570844-B1 AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS ARCUS BIOSCIENCES INC (US) 2023-09-06 EP disclosed
WO-2018136700-A1 AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS ARCUS BIOSCIENCES, INC. (US) 2018-07-26 WO disclosed